• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸化的蛋白激酶B上调去势抵抗性前列腺癌中血管紧张素II 1型受体的表达。

Phosphorylated Akt up-regulates angiotensin II type-1 receptor expression in castration resistant prostate cancer.

作者信息

Kosaka Takeo, Miyajima Akira, Shirotake Suguru, Kikuchi Eiji, Oya Mototsugu

机构信息

Department of Urology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.

出版信息

Prostate. 2011 Oct 1;71(14):1510-7. doi: 10.1002/pros.21367. Epub 2011 Feb 14.

DOI:10.1002/pros.21367
PMID:21321983
Abstract

BACKGROUND

Accumulating evidences has suggested that the renin-angiotensin system (RAS) participates in the regulation of tumor angiogenesis. We previously demonstrated that castration-resistant prostate cancer (CRPC) showed significantly higher angiotensin II (Ang II) type-1 receptor (AT1R) expression, and that AT1R blockade (ARB) exerted protective effects by inhibiting angiogenesis. However, the detailed molecular mechanisms for the increase of AT1R expression in CRPC has not been fully elucidated yet.

METHODS

In this study we used C4-2 and C4-2AT6 cells, which were PTEN-null, androgen receptor (AR) positive, PSA-producing CRPC cell lines. We investigated the association between phosphorylated Akt (pAkt) and AT1R expression, and used LY294002 as a PI3K/Akt inhibitor.

RESULTS

Western blot analysis revealed C4-2AT6 cells showed significantly higher pAkt expression than C4-2 cells, although there were no significant differences in total Akt (tAkt) expression. Immunohistochemical (IHC) analysis also revealed significant higher pAkt expression in C4-2AT6 tumors obtained from castrated male nude mice. These results indicated that C4-2AT6 cells acquired elevated pAkt status under androgen-ablated treatment in vitro. Treatment with LY294002 at the same dose reduced the viability of C4-2AT6 more effectively than that of C4-2, reflecting the dependency of cancer cells on PI3K/Akt pathway. The up-regulated AT1R expression in C4-2AT6 cells was reduced by LY294002 in a dose-dependent manner. On the other hand, in C4-2 cells, serum starvation induced pAkt up-regulation, which led to an increase of AT1R expression.

CONCLUSIONS

These findings indicated that up-regulation of pAkt contributed to elevated AT1R expression in CRPC.

摘要

背景

越来越多的证据表明肾素 - 血管紧张素系统(RAS)参与肿瘤血管生成的调节。我们之前证明去势抵抗性前列腺癌(CRPC)显示出明显更高的血管紧张素II(Ang II)1型受体(AT1R)表达,并且AT1R阻断(ARB)通过抑制血管生成发挥保护作用。然而,CRPC中AT1R表达增加的详细分子机制尚未完全阐明。

方法

在本研究中,我们使用了C4 - 2和C4 - 2AT6细胞,它们是PTEN缺失、雄激素受体(AR)阳性、产生前列腺特异性抗原(PSA)的CRPC细胞系。我们研究了磷酸化Akt(pAkt)与AT1R表达之间的关联,并使用LY294002作为PI3K/Akt抑制剂。

结果

蛋白质印迹分析显示,尽管总Akt(tAkt)表达没有显著差异,但C4 - 2AT6细胞的pAkt表达明显高于C4 - 2细胞。免疫组织化学(IHC)分析还显示,在去势雄性裸鼠获得的C4 - 2AT6肿瘤中,pAkt表达明显更高。这些结果表明,C4 - 2AT6细胞在体外雄激素剥夺治疗下获得了升高的pAkt状态。用相同剂量的LY294002处理比C4 - 2更有效地降低了C4 - 2AT6的活力,反映了癌细胞对PI3K/Akt途径的依赖性。LY294002以剂量依赖性方式降低了C4 - 2AT6细胞中上调的AT1R表达。另一方面,在C4 - 2细胞中,血清饥饿诱导pAkt上调,这导致AT1R表达增加。

结论

这些发现表明pAkt的上调导致CRPC中AT1R表达升高。

相似文献

1
Phosphorylated Akt up-regulates angiotensin II type-1 receptor expression in castration resistant prostate cancer.磷酸化的蛋白激酶B上调去势抵抗性前列腺癌中血管紧张素II 1型受体的表达。
Prostate. 2011 Oct 1;71(14):1510-7. doi: 10.1002/pros.21367. Epub 2011 Feb 14.
2
Ets-1 and hypoxia inducible factor-1alpha inhibition by angiotensin II type-1 receptor blockade in hormone-refractory prostate cancer.血管紧张素 II 型 1 受体阻断剂抑制激素难治性前列腺癌中的 Ets-1 和缺氧诱导因子-1α。
Prostate. 2010 Feb 1;70(2):162-9. doi: 10.1002/pros.21049.
3
Dual PI3K/mTOR inhibitor NVP-BEZ235 sensitizes docetaxel in castration resistant prostate cancer.双重 PI3K/mTOR 抑制剂 NVP-BEZ235 增敏多西他赛治疗去势抵抗性前列腺癌。
J Urol. 2014 Jan;191(1):227-34. doi: 10.1016/j.juro.2013.07.101. Epub 2013 Aug 15.
4
Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway.血管紧张素 II/血管紧张素 II 型受体(AT1R)信号通过 PI3-激酶/Akt 通路促进 MCF-7 乳腺癌细胞的存活。
J Cell Physiol. 2010 Oct;225(1):168-73. doi: 10.1002/jcp.22209.
5
Regulation of monocyte chemoattractant protein-1 through angiotensin II type 1 receptor in prostate cancer.血管紧张素 II 型 1 受体对前列腺癌细胞趋化因子 MCP-1 的调控作用。
Am J Pathol. 2012 Mar;180(3):1008-1016. doi: 10.1016/j.ajpath.2011.11.027. Epub 2012 Jan 6.
6
Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer.血管紧张素II 1型受体拮抗剂作为前列腺癌中的血管生成抑制剂
Prostate. 2007 Jan 1;67(1):41-9. doi: 10.1002/pros.20486.
7
Synergistic targeting of PI3K/AKT pathway and androgen receptor axis significantly delays castration-resistant prostate cancer progression in vivo.协同靶向 PI3K/AKT 通路和雄激素受体轴显著延缓体内去势抵抗性前列腺癌的进展。
Mol Cancer Ther. 2013 Nov;12(11):2342-55. doi: 10.1158/1535-7163.MCT-13-0032. Epub 2013 Aug 21.
8
Complex impacts of PI3K/AKT inhibitors to androgen receptor gene expression in prostate cancer cells.PI3K/AKT抑制剂对前列腺癌细胞中雄激素受体基因表达的复杂影响。
PLoS One. 2014 Oct 31;9(10):e108780. doi: 10.1371/journal.pone.0108780. eCollection 2014.
9
Up-regulation of the Ang II/AT1 receptor may compensate for the loss of gastric antrum ICC via the PI3k/Akt signaling pathway in STZ-induced diabetic mice.在链脲佐菌素诱导的糖尿病小鼠中,血管紧张素II/1型血管紧张素受体的上调可能通过PI3k/Akt信号通路来补偿胃窦部ICC的缺失。
Mol Cell Endocrinol. 2016 Mar 5;423:77-86. doi: 10.1016/j.mce.2016.01.002. Epub 2016 Jan 8.
10
Angiotensin II enhances the proliferation of Natural Killer/T-cell lymphoma cells via activating PI3K/Akt signaling pathway.血管紧张素 II 通过激活 PI3K/Akt 信号通路增强自然杀伤/T 细胞淋巴瘤细胞的增殖。
Biosci Rep. 2020 Oct 30;40(10). doi: 10.1042/BSR20202388.

引用本文的文献

1
Loss of phosphatase and tensin homolog expression castration-sensitive prostate cancer predicts outcomes in men after prostatectomy.磷酸酶和张力蛋白同源物表达缺失的去势敏感性前列腺癌可预测前列腺切除术后男性的预后。
Int J Urol. 2025 Jan;32(1):39-44. doi: 10.1111/iju.15592. Epub 2024 Oct 1.
2
Selective killing of castration-resistant prostate cancer cells by formycin A via the ATF4-CHOP axis.福米韦生通过ATF4-CHOP轴选择性杀伤去势抵抗性前列腺癌细胞。
Cancer Sci. 2024 Dec;115(12):3997-4007. doi: 10.1111/cas.16349. Epub 2024 Sep 26.
3
Influence of response to prior docetaxel on sensitivity to cabazitaxel in prostate cancer patients with PTEN alterations.
PTEN 改变的前列腺癌患者对多西他赛治疗反应的影响与 cabazitaxel 敏感性的关系。
Cancer Sci. 2022 Sep;113(9):3161-3168. doi: 10.1111/cas.15473. Epub 2022 Jul 18.
4
TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer.TUBB3 逆转前列腺癌对多西他赛和卡巴他赛的耐药性。
Int J Mol Sci. 2019 Aug 13;20(16):3936. doi: 10.3390/ijms20163936.
5
Reactive oxygen species induction by cabazitaxel through inhibiting Sestrin-3 in castration resistant prostate cancer.卡巴他赛通过抑制去势抵抗性前列腺癌中的Sestrin-3诱导活性氧生成
Oncotarget. 2017 Sep 21;8(50):87675-87683. doi: 10.18632/oncotarget.21147. eCollection 2017 Oct 20.
6
Is DHT Production by 5α-Reductase Friend or Foe in Prostate Cancer?5α-还原酶导致的二氢睾酮增加对前列腺癌是敌是友?
Front Oncol. 2014 Sep 16;4:247. doi: 10.3389/fonc.2014.00247. eCollection 2014.
7
Expression and clinical significance of angiotensin II type 1 receptor in human hepatocellular carcinoma.血管紧张素II 1型受体在人肝细胞癌中的表达及临床意义
Exp Ther Med. 2014 Feb;7(2):323-328. doi: 10.3892/etm.2013.1411. Epub 2013 Nov 15.
8
Human castration resistant prostate cancer rather prefer to decreased 5α-reductase activity.人去势抵抗性前列腺癌患者更倾向于降低 5α-还原酶活性。
Sci Rep. 2013;3:1268. doi: 10.1038/srep01268.